Skip to content

Gross margin at other companies

LivaNova logo
LivaNovaLIVN
67.5%-0.5pp
ICU Medical logo
ICU MedicalICUI
37.9%+2.8pp
Edwards Lifesciences logo
Edwards LifesciencesEW
77.9%-1.6pp
United Therapeutics logo
United TherapeuticsUTHR
86.6%-2.4pp
OSI Systems logo
OSI SystemsOSIS
32.8%-1.1pp

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.55B+50.6%
Enterprise value$2.5B+66.0%
P/E14.8×-19.8×
P/S+0.5×

Profitability

See full
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Calculated from TransMedics Group, Inc.’s reported figures.

Based on trailing twelve months.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TransMedics Group, Inc.'s gross margin?
TransMedics Group, Inc. (TMDX) reported gross margin of 59.1% in Q1 2026.
How has TransMedics Group, Inc.'s gross margin changed year-over-year?
TransMedics Group, Inc.'s gross margin decreased by 0.6% year-over-year, from 59.5% to 59.1%.
What is the long-term trend for TransMedics Group, Inc.'s gross margin?
Over 5 years (2020 to 2025), TransMedics Group, Inc.'s gross margin has grown at a -1.6% compound annual growth rate (CAGR), from 64.9% to 59.9%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.